Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Fluorouracil and Calcipotriol vs 5-Fluorouracil for Actinic Keratosis
NCT06499415Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2024
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of AKP01 in actinic keratosis (AK), sponsored by Maastricht University Medical Center+. Started Sep 2024; status: completed.
02
Drugs
AKP01
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT06499415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06499415.